CTOs on the Move

JenaValve

www.jenavalve.com

 
JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.
  • Number of Employees: 100-250
  • Annual Revenue: $250-500 Million
  • www.jenavalve.com
  • 1000 N. West Street Suite 1200
    Wilmington, DE USA 19801
  • Phone: 302.295.4897

Executives

Name Title Contact Details

Similar Companies

Atlanta Pediatric Therapy

Atlanta Pediatric Therapy is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HemCon Medical Technologies, Inc.

HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. With a 36,000 sq. ft. state of the art manufacturing facility, the Company has additional commercial operations in Ireland and the Czech Republic.

SoftMed Systems

SoftMed Systems is a Silver Spring, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gentis Inc

Gentis Inc is a Wayne, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Caption Health

Caption Health was founded in 2013 on a simple but powerful concept: what if we could use technology to emulate the expertise of highly trained medical experts and put that ability into the hands of every care provider?